Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Vismodegib bulk supplier for pharma manufacturers

Vismodegib 150mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 150mg

Reference Brands: ERIVEDGE (USA/EU)

Category: Oncology Cancer Care

Vismodegib is an oral small-molecule inhibitor of the Hedgehog signaling pathway, specifically targeting the Smoothened (SMO) receptor. It is used in the treatment of adults with metastatic or locally advanced basal cell carcinoma that cannot be treated with surgery or radiation. By blocking abnormal cell signaling, Vismodegib helps slow or stop the growth of cancerous cells. Erivedge is taken orally once daily and is among the first targeted therapies developed for advanced skin cancer.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Vismodegib — third party manufacturing & bulk supply

Vismodegib 150mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Vismodegib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Vismodegib →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Vismodegib is used to treat adults with metastatic or locally advanced basal cell carcinoma (BCC) that cannot be treated with surgery or radiation. It works by inhibiting the Hedgehog signaling pathway, which is involved in the growth and development of certain cancers, thereby slowing or stopping tumor progression.

Vismodegib is made from Vismodegib, a small-molecule Hedgehog pathway inhibitor that specifically targets and blocks the Smoothened (SMO) receptor involved in cancer cell signaling.

The trade name of Vismodegib is Erivedge.

Vismodegib (Erivedge) is developed and manufactured by Genentech, a member of the Roche Group, and marketed globally under approved regulatory pathways.

The generic name of Vismodegib is Vismodegib.

The brand name of Vismodegib is Erivedge.

Vismodegib is manufactured in the United States and Switzerland by Genentech and Roche under strict GMP-certified facilities for oncology therapeutics.

Related Products

Fruquin 5 Mg (Fruquintinib)

Strength:
5 Mg

Form: Capsules

Reference Brands: Everest Bangladesh altd.

View Details
Vorinostat

Strength:
100 mg

Form: Capsules

Reference Brands: Zolinza (USA/EU), Vornat (India)

View Details
Panobinostat Lactate

Strength:
10 mg, 15 mg, 20 mg

Form: Capsules

Reference Brands: Farydak (USA/EU),

View Details
Gilteritinib

Strength:
40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.